Robert Negrin/stanford.edu
May 23, 2026, 16:33
Why Are We Dismantling What Powers Humanity and the Global Economy? – ASH
American Society of Hematology (ASH) shared a post on LinkedIn about a recent article by Robert Negrin, published in The Hematologist, adding:
”Just like last year, devastating cuts in NIH funding have been proposed to Congress, threatening opportunities to advance small molecules, gene and cell therapies, and many other critical avenues of investigation, as well as directly affecting the career decisions of young physicians and scientists.
Now is the time to advocate and share your stories.
Learn more about what’s at risk.”
Title: Here We Go Again
Authors: Robert Negrin
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 8, 2026, 05:53Excellent PhD Defense by Roberta Cirsmaru on Gene Therapy for Hemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Jul 8, 2026, 05:48Riccardo Menandro: How Lipid Nanoparticles Are Shaping the Future of Rare Disease and Hemophilia Treatment
-
Jul 8, 2026, 05:39Daniel Victor Ortigoza: New Evidence from ATLANTIS-4D-CT on Apixaban and Subclinical Valve Thrombosis
-
Jul 8, 2026, 04:50Reza Bavarsad Shahripour: New AHA Guidance on Cryptogenic Stroke with Reduced Left Ventricular Function
-
Jul 7, 2026, 23:20Balaji Balagani: Exploring Pulmonary Embolism
-
Jul 7, 2026, 23:03Roxana González Mazarío: The Phenotype-Specific Cardiovascular Risks in AAV
-
Jul 7, 2026, 22:52Harry Spoelstra: LongC0VID Still has Zero Proven Treatments
-
Jul 7, 2026, 22:39Satya K. Morar: Acute Portal Vein Thrombosis as an Exceptionally Rare Complication of Liver Biopsy in CVID
-
Jul 7, 2026, 22:23Aravind Palraj: Antiphospholipid Syndrome is not Just ‘Start Warfarin and Follow INR’